InvestorsHub Logo
Followers 144
Posts 27636
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Tuesday, 04/28/2020 12:12:49 PM

Tuesday, April 28, 2020 12:12:49 PM

Post# of 3897
Is Redhill Biopharma (RDHL) Outperforming Other Medical Stocks This Year?

Based on the most recent data, RDHL has returned 41.68% so far this year. Meanwhile, stocks in the Medical group have lost about 1.49% on average. As we can see, Redhill Biopharma is performing better than its sector in the calendar year.
Breaking things down more, RDHL is a member of the Medical - Drugs industry, which includes 172 individual companies and currently sits at #8 in the Zacks Industry Rank. On average, this group has lost an average of 9.40% so far this year, meaning that RDHL is performing better in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track RDHL. The stock will be looking to continue its solid performance.


https://finance.yahoo.com/news/redhill-biopharma-rdhl-outperforming-other-153003116.html


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News